|
Name |
4-hydroxy-2-nonyl-6-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)benzoic acid
|
Molecular Formula | C24H42O8 | |
IUPAC Name* |
4-hydroxy-6-nonyl-2-[[2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]oxymethyl]cyclohexene-1-carboxylicacid
|
|
SMILES |
CCCCCCCCCC1CC(O)CC(COC2CC(CO)C(O)C(O)C2O)=C1C(=O)O
|
|
InChI |
InChI=1S/C24H42O8/c1-2-3-4-5-6-7-8-9-15-10-18(26)11-17(20(15)24(30)31)14-32-19-12-16(13-25)21(27)23(29)22(19)28/h15-16,18-19,21-23,25-29H,2-14H2,1H3,(H,30,31)/t15-,16-,18+,19-,21+,22-,23+/m1/s1
|
|
InChIKey |
HFWLUDJYSUZRIE-KGLKZMTNSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 458.59 | ALogp: | 1.8 |
HBD: | 6 | HBA: | 7 |
Rotatable Bonds: | 13 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 147.7 | Aromatic Rings: | 2 |
Heavy Atoms: | 32 | QED Weighted: | 0.231 |
Caco-2 Permeability: | -5.429 | MDCK Permeability: | 0.00017117 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.027 |
Human Intestinal Absorption (HIA): | 0.969 | 20% Bioavailability (F20%): | 0.975 |
30% Bioavailability (F30%): | 0.995 |
Blood-Brain-Barrier Penetration (BBB): | 0.199 | Plasma Protein Binding (PPB): | 82.72% |
Volume Distribution (VD): | 0.539 | Fu: | 9.72% |
CYP1A2-inhibitor: | 0.011 | CYP1A2-substrate: | 0.081 |
CYP2C19-inhibitor: | 0.006 | CYP2C19-substrate: | 0.314 |
CYP2C9-inhibitor: | 0.001 | CYP2C9-substrate: | 0.945 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.097 |
CYP3A4-inhibitor: | 0.008 | CYP3A4-substrate: | 0.014 |
Clearance (CL): | 1.514 | Half-life (T1/2): | 0.527 |
hERG Blockers: | 0.012 | Human Hepatotoxicity (H-HT): | 0.137 |
Drug-inuced Liver Injury (DILI): | 0.965 | AMES Toxicity: | 0.016 |
Rat Oral Acute Toxicity: | 0.671 | Maximum Recommended Daily Dose: | 0.104 |
Skin Sensitization: | 0.033 | Carcinogencity: | 0.25 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.479 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005852 | 0.356 | D0XN8C | 0.361 | ||||
ENC004171 | 0.354 | D0I4DQ | 0.331 | ||||
ENC004172 | 0.354 | D03JSJ | 0.305 | ||||
ENC002066 | 0.353 | D09SRR | 0.304 | ||||
ENC005599 | 0.343 | D00CTS | 0.286 | ||||
ENC004173 | 0.333 | D09ANG | 0.286 | ||||
ENC003174 | 0.320 | D0H2YX | 0.276 | ||||
ENC002302 | 0.316 | D00STJ | 0.270 | ||||
ENC001227 | 0.313 | D03ZJE | 0.267 | ||||
ENC004781 | 0.311 | D01WUA | 0.265 |